Figure 1
Course of AchR-ab over almost three years, showing a positive effect of immunosuppression at onset and after the fifth myasthenic crises despite PSC.
Figure 1 | Journal of Medical Case Reports
Course of AchR-ab over almost three years, showing a positive effect of immunosuppression at onset and after the fifth myasthenic crises despite PSC.
Journal of Medical Case Reports